23:29 EDT Cathie Wood’s ARK Investment buys 342K shares of 10x Genomics (TXG) today
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TXG:
- 10x Genomics price target lowered to $18 from $26 at Morgan Stanley
- 10x Genomics: Buy Rating Affirmed Amid Consumable Growth and Legal Resolutions
- Hold Rating Maintained for 10x Genomics Amid Settlement Gains and Macroeconomic Challenges
- 10x Genomics Settles Litigation with Bruker Corporation
- 10x Genomics announces patent litigation settlement with Bruker